Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Retinoblastoma binding protein 4 represses HIV-1 long terminal repeat-mediated transcription by recruiting NR2F1 and histone deacetylase.

Wang J, Yang Z, Cheng L, Lu L, Pan K, Yang J, Wu N.

Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):934-944. doi: 10.1093/abbs/gmz082.

PMID:
31435636
3.

Lysine-specific demethylase 1 cooperates with BRAF-histone deacetylase complex 80 to enhance HIV-1 Tat-mediated transactivation.

Liu Y, Zhou D, Qi D, Feng J, Liu Z, Hu Y, Shen W, Liu C, Kong X.

Virus Genes. 2018 Oct;54(5):662-671. doi: 10.1007/s11262-018-1589-5. Epub 2018 Aug 13.

PMID:
30105631
4.

NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC.

EMBO J. 2006 Jan 11;25(1):139-49. Epub 2005 Dec 1.

5.

Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.

Archin NM, Keedy KS, Espeseth A, Dang H, Hazuda DJ, Margolis DM.

AIDS. 2009 Sep 10;23(14):1799-806. doi: 10.1097/QAD.0b013e32832ec1dc.

6.

Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes.

Moody RR, Lo MC, Meagher JL, Lin CC, Stevers NO, Tinsley SL, Jung I, Matvekas A, Stuckey JA, Sun D.

J Biol Chem. 2018 Feb 9;293(6):2125-2136. doi: 10.1074/jbc.M117.811463. Epub 2017 Dec 20.

7.

Transcriptional repression of human immunodeficiency virus type 1 by AP-4.

Imai K, Okamoto T.

J Biol Chem. 2006 May 5;281(18):12495-505. Epub 2006 Mar 15.

8.
9.

The structure of the core NuRD repression complex provides insights into its interaction with chromatin.

Millard CJ, Varma N, Saleh A, Morris K, Watson PJ, Bottrill AR, Fairall L, Smith CJ, Schwabe JW.

Elife. 2016 Apr 21;5:e13941. doi: 10.7554/eLife.13941.

10.

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

Jiang G, Espeseth A, Hazuda DJ, Margolis DM.

J Virol. 2007 Oct;81(20):10914-23. Epub 2007 Aug 1.

11.

Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation.

Schultz LE, Haltom JA, Almeida MP, Wierson WA, Solin SL, Weiss TJ, Helmer JA, Sandquist EJ, Shive HR, McGrail M.

Dis Model Mech. 2018 Jun 15;11(6). pii: dmm034124. doi: 10.1242/dmm.034124.

12.

Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.

Ylisastigui L, Kaur R, Johnson H, Volker J, He G, Hansen U, Margolis D.

J Virol. 2005 May;79(10):5952-62.

13.

The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.

Lucera MB, Tilton CA, Mao H, Dobrowolski C, Tabler CO, Haqqani AA, Karn J, Tilton JC.

J Virol. 2014 Sep;88(18):10803-12. doi: 10.1128/JVI.00320-14. Epub 2014 Jul 9.

14.

The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.

Coull JJ, Romerio F, Sun JM, Volker JL, Galvin KM, Davie JR, Shi Y, Hansen U, Margolis DM.

J Virol. 2000 Aug;74(15):6790-9.

15.

RBBP4 regulates histone deacetylation and bipolar spindle assembly during oocyte maturation in the mouse.

Balboula AZ, Stein P, Schultz RM, Schindler K.

Biol Reprod. 2015 Apr;92(4):105. doi: 10.1095/biolreprod.115.128298. Epub 2015 Mar 18.

16.

Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation.

Kuai Q, Lu X, Qiao Z, Wang R, Wang Y, Ye S, He M, Wang Y, Zhang T, Wu H, Ren S, Yu Q.

J Med Virol. 2018 Sep;90(9):1478-1485. doi: 10.1002/jmv.25207. Epub 2018 May 25.

PMID:
29704439
17.

HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.

Zhang HS, Ruan Z, Sang WW.

J Cell Physiol. 2011 Dec;226(12):3385-91. doi: 10.1002/jcp.22691.

PMID:
21344388
19.

Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.

Lu HK, Gray LR, Wightman F, Ellenberg P, Khoury G, Cheng WJ, Mota TM, Wesselingh S, Gorry PR, Cameron PU, Churchill MJ, Lewin SR.

PLoS One. 2014 Nov 19;9(11):e113341. doi: 10.1371/journal.pone.0113341. eCollection 2014.

20.

Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.

Wightman F, Lu HK, Solomon AE, Saleh S, Harman AN, Cunningham AL, Gray L, Churchill M, Cameron PU, Dear AE, Lewin SR.

AIDS. 2013 Nov 28;27(18):2853-62. doi: 10.1097/QAD.0000000000000067.

Supplemental Content

Support Center